Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00397943
Status:
COMPLETED
Last Update Posted:
2019-06-19
First Post:
2006-11-09
Brief Title:
Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 01 Months to Healthy Adults
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline